Ophthalmic Drug Delivery Online Conference

15th of September 2021, 15:00 CET

BigMarker platform

ABOUT THE CONFERENCE

We are pleased to welcome you to the Ophthalmic Drug Delivery Online Conference that will take place on the 15th of  September, 2021 at 15:00 CET on the BigMarker platform.

Join us for an event which offers a meeting place for top manufacturers, researchers, academics, decision-makers and other business professionals who are keen to share their knowledge and experience in the treatment of ocular disease, innovations in ophthalmic drug delivery technologies, and the utterly unique challenges.

The conference represents a unique opportunity for learning, exchanging opinions, and expanding one’s network enabled by live presentations followed by dynamic Q&A sessions – providing the attendees with valuable insights from leaders in the ophthalmic sphere.

Key points

  • Formulation for Ophthalmic Drug Delivery
  • Therapeutic Nanotechnology
  • Ocular Tolerability
  • Minimization of Precorneal Drug Loss
  • Topical Drug Delivery to the Retina

Who should attend

CEOs / VPs / Drug Developers /Academics and Researchers/ R&D Specialists / Heads / Professors /Senior Lecturers CROs / CMOs / Pharmacologists /Scientists and Medical Doctors of:

  • Ocular Therapy and Drug Delivery
  • Medical Safety
  • Ophthalmology
  • Retinal Health
  • Ophthalmic Pharmacology
  • Process Development
  • Biotechnologies in Ocular Drug Delivery
  • Ocular Biology and Immunology
  • Clinical Pharmaceuticals

3-HOUR ONLINE CONFERENCE INCLUDES

  • 4+ different topics
  • panel discussion
  • networking with business professionals and industry experts
  • additional materials
If you would like to participate, kindly book your spot. The seats are limited.
Broadcast Link will be provided via email post registration.

Event Schedule

15:00 – 15:10 CET

Welcome and opening remarks from the moderator

15:10 – 15:35 CET

Addressing Challenges in Ophthalmic Drug Delivery + Q&A

15:35 – 16:00 CET

Drug Delivery to the Eye: Challenges and Opportunities for Long-acting Drug Delivery Systems + Q&A

16:00 – 16:10 CET

BREAK

16:10 – 16:35 CET

Novel Small Molecule Technology to Deliver Novel More Effective and Durable Treatment Alternatives for Diabetic Retinopathy and Wet Macular Degeneration + Q&A

16:35 – 17:00 CET

Fill & Finish of Complex Drug Products Including Ophthalmics+ Q&A

17:00 – 17:10 CET

BREAK

17:10 – 17:35 CET

Panel Discussion: Latest Trends of Topical Drug Delivery to the Retina

17:35 – 17:40 CET

CLOSING SESSION REMARKS

SPEAKERS

Robert W. Lee, Ph.D.
President – CDMO Division
Lubrizol Life Science Health (LLS Health)
Dr Thakur Raghu Raj Singh
Founder & CTO, Chair Ocular Delivery FG, Controlled Release Society
Re-Vana Therapeutics
Alan J Franklin
Founder
ForwardVue Pharma
Carole Delauney
Director of Business Development
swissfillon

OUR PARTNERS

Contact Us

Tatiana Naumova
Marketing Manager
Tel.: +420 228 227 162
E-mail: tatiana.naumova@bcfgroup.eu
Benazir Jursunbek
Operations and Conference Manager
Tel.: +420 228 227 164
E-mail: operations@bcf-events.com